Short Interest in Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) Drops By 38.5%

Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) was the target of a significant drop in short interest in April. As of April 30th, there was short interest totaling 31,421 shares, a drop of 38.5% from the April 15th total of 51,122 shares. Based on an average daily trading volume, of 23,330 shares, the days-to-cover ratio is currently 1.3 days. Currently, 0.1% of the shares of the stock are short sold.

Analyst Ratings Changes

Separately, Weiss Ratings lowered shares of Zhengye Biotechnology from a “sell (d)” rating to a “sell (d-)” rating in a research note on Friday. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company presently has an average rating of “Sell”.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the stock. Citadel Advisors LLC acquired a new stake in shares of Zhengye Biotechnology during the third quarter worth approximately $31,000. Millennium Management LLC acquired a new stake in shares of Zhengye Biotechnology in the third quarter valued at $38,000. WINTON GROUP Ltd acquired a new stake in shares of Zhengye Biotechnology in the third quarter valued at $56,000. Geode Capital Management LLC acquired a new stake in shares of Zhengye Biotechnology in the second quarter valued at $174,000. Finally, Invesco Ltd. acquired a new stake in shares of Zhengye Biotechnology in the second quarter valued at $220,000.

Zhengye Biotechnology Trading Down 1.4%

ZYBT traded down $0.01 on Monday, hitting $0.94. The company had a trading volume of 314 shares, compared to its average volume of 157,270. The company’s fifty day moving average price is $0.92 and its 200 day moving average price is $1.31. Zhengye Biotechnology has a 1-year low of $0.68 and a 1-year high of $13.08. The company has a quick ratio of 0.82, a current ratio of 1.14 and a debt-to-equity ratio of 0.03.

Zhengye Biotechnology (NASDAQ:ZYBT) last announced its earnings results on Tuesday, April 28th. The company reported ($0.08) earnings per share (EPS) for the quarter. The company had revenue of $3.97 million for the quarter.

Zhengye Biotechnology Company Profile

Zhengye Biotechnology Holding Limited is a veterinary vaccine manufacturer which encompasses research, development, manufacturing and sales of veterinary vaccines, with a focus on livestock vaccine principally in China. Zhengye Biotechnology Holding Limited is based in Jilin, China.